Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Lille
About this trial
This is a common care study. A study for evaluating the quality of balloon inflation and stent application will be performed in 2D angiography alone in the control group and then by 2D and OCT angiography for the experimental group. The benefit could be an improvement in the results of revascularization of femoropopliteal lesions thanks to OCT which allows a 3D visualization of the arterial lumen.
Eligibility criteria
Qualifiers
Patient over 18 years old
Femoral-popliteal lesion TASC-C or TASC-D de novo (F1 to P1)
Starting lesion on the superficial femoral artery and not extending beyond the intercondylar notch (P2)
≥1 continuous permeable leg axis directly injecting the plantar arch
Disqualifiers
Patient under personal protection regime (tutorship, guardianship)
Absence of arterial axis in permeable leg
Patient presenting a limb acute ischaemia (chart evolving since less than 14 days)
Patient without favorable element to consider healing
Trial design
Treatments tested in this trial
- femoropopliteal revascularization for TASC C or TASC D lesion
Treatment groups
166 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Hospital, Lille
Lead sponsor
Abbott
Collaborator
Source ClinicalTrials.gov